A Comparison Study Between Protopic (Tacrolimus) Ointment and Elidel (Pimecrolimus) Cream in Treating Subjects With Atopic Dermatitis
NCT00666302 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 413
Last updated 2014-09-18
Summary
A study to compare efficacy of Protopic Ointment to that of Elidel Cream in treating patients with Atopic Dermatitis
Conditions
- Dermatitis, Atopic
Interventions
- DRUG
-
tacrolimus ointment
topical
- DRUG
-
pimecrolimus cream
topical
Sponsors & Collaborators
-
Astellas Pharma Inc
lead INDUSTRY
Principal Investigators
-
Use central contact · Astellas Pharma US, Inc.
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 16 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2002-10-31
- Primary Completion
- 2003-11-30
- Completion
- 2003-11-30
Countries
- United States
- Canada
Study Locations
More Related Trials
-
Protopic Ointment in Children Atopic Eczema
NCT00689832 ·Status: COMPLETED ·Phase: PHASE4
-
Bilateral Comparison Study of Elidel 1% and Hylatopic Plus Emollient Foam for the Treatment of Subjects With Atopic Dermatitis
NCT01202149 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of Lindioil (Indigo Naturalis Oil Extract) Ointment to Protopic® Ointment 0.1% in Treating Atopic Dermatitis
NCT03614221 ·Status: COMPLETED ·Phase: PHASE2
-
Long-term Safety of Protopic in Atopic Eczema
NCT00560378 ·Status: COMPLETED ·Phase: PHASE3
-
Bioequivalence of Two Tacrolimus 0.1% Topical Ointment Formulations in Patients With Atopic Dermatitis
NCT00833079 ·Status: COMPLETED ·Phase: PHASE1
-
Pimecrolimus Cream 1% Plus Topical Corticosteroid in Patients (2-17 Years of Age) With Severe Atopic Dermatitis
NCT00121381 ·Status: COMPLETED ·Phase: PHASE4
-
Pimecrolimus Cream 1% (Elidel®) and Medicated Device Cream (EletoneTM) in the Treatment and Maintenance of Atopic Dermatitis.
NCT01177566 ·Status: COMPLETED ·Phase: PHASE4
-
A Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Protopic for the Treatment of Atopic Dermatitis
NCT00475605 ·Status: TERMINATED
-
Bioequivalence Study of Pimecrolimus Cream, 1% and Elidel® Cream, 1% in Mild to Moderate Atopic Dermatitis
NCT03107611 ·Status: COMPLETED ·Phase: PHASE3
-
Treatment and Control of Atopic Dermatitis With 0.1% Tacrolimus Ointment
NCT00480610 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Generic Pimecrolimus Cream, 1% in the Treatment of Mild to Moderate Atopic Dermatitis
NCT02896101 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate the Efficacy and Safety of 0.1% and 0.03% Tacrolimus Ointment Administered in Adults With Moderate to Severe Atopic Dermatitis
NCT00691145 ·Status: COMPLETED ·Phase: PHASE3
-
Study of the Safety and Efficacy of Tacrolimus Ointment in Treating Chronic Allergic Contact Dermatitis
NCT00667056 ·Status: COMPLETED ·Phase: PHASE4
-
Distribution of Tacrolimus in Skin, Atopic Dermatitis
NCT00534508 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of the Antipruritic Effect of Elidel (Pimecrolimus) in Non-atopic Pruritic Disease
NCT00507832 ·Status: COMPLETED ·Phase: PHASE2
-
Treatment and Control of Atopic Dermatitis With 0.03% Tacrolimus Ointment
NCT00480896 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Bioequivalence of Pimecrolimus Cream 1% and Elidel R in Treatment of Mild to Moderate Atopic Dermatitis
NCT03297502 ·Status: COMPLETED ·Phase: PHASE3
-
Elidel-Study: Elidel in Patients With Atopic Dermatitis
NCT00180141 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of Pimecrolimus Cream 1% in Patients (2 to 11 Years Old) With Mild to Moderate Facial Atopic Dermatitis
NCT00130364 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Atopic Dermatitis
NCT02583022 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Safety, Tolerability and Pharmacokinetic Properties of IN-A002 Ointment in Healthy Adult Male Volunteers and Mild to Moderate Atopic Dermatitis Patients
NCT05729074 ·Status: UNKNOWN ·Phase: PHASE1
-
Study of Equivalence of Generic Pimecrolimus Cream 1% and Elidel® 1% in Subjects With Mild to Moderate Atopic Dermatitis
NCT02791308 ·Status: COMPLETED ·Phase: PHASE3
-
Tacrolimus Ointment Long Term Safety in Young Children With Atopic Dermatitis
NCT00560326 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate the Response to Treatment and Safety of 0.03% Tacrolimus (FK506) Ointment Administered in Pediatric Patients With Moderate to Severe Atopic Dermatitis
NCT00691262 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Trial to Assess the Efficacy and Safety of Tacrolimus Ointment Treatment of Atopic Dermatitis in Adult Patients
NCT00523952 ·Status: COMPLETED ·Phase: PHASE3